Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Cancer Biology & Therapy|September 13, 2013
The S492R EGFR ectodomain mutation is never detected in KRAS wild-type colorectal carcinoma before exposure to EGFR monoclonal antibodiesClaudia Esposito, Anna Maria Rachiglio, Maria Libera La Porta, et al.
Cancer Biology & Therapy|June 5, 2016
BRAF V600E mutation in metastatic colorectal cancer: Methods of detection and correlation with clinical and pathologic featuresCristin Roma, Anna Maria Rachiglio, Raffaella Pasquale, et al.
Future Oncology (London, England)|June 5, 2015
EGFR mutations in lung cancer: from tissue testing to liquid biopsyFrancesca Fenizia, Antonella De Luca, Raffaella Pasquale, et al.
Journal of Cellular Biochemistry|September 20, 2012
Molecular diagnostics and personalized medicine in oncology: challenges and opportunitiesNicola Normanno, Anna Maria Rachiglio, Cristin Roma, et al.
Frontiers in Oncology|November 4, 2021
Co-Occurrence of Myeloid and Lymphoid Neoplasms: Clinical Characterization and Impact on Outcome. A Single-Center Cohort StudyCristina Bucelli, Bruno Fattizzo, Daniele Cattaneo, et al.
Pharmacogenomics|August 8, 2015
Assessment of high-sensitive methods for the detection of EGFR mutations in circulating free tumor DNA from NSCLC patientsRaffaella Pasquale, Francesca Fenizia, Riziero Esposito Abate, et al.
Oncotarget|July 30, 2014
p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumabPatrizia Vici, Francesca Sperati, Marcello Maugeri-Saccà, et al.
Oncotarget|July 25, 2016
Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinomaAnna Maria Rachiglio, Riziero Esposito Abate, Alessandra Sacco, et al.
The Oncologist|March 19, 2022
Liquid Biopsy Testing for the Management of Patient with Non-Small Cell Lung Cancer Carrying a Rare Exon-20 EGFR InsertionAlessandro Morabito, Anna Manzo, Agnese Montanino, et al.
Cancers|September 28, 2019
Liquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with GefitinibRiziero Esposito Abate, Raffaella Pasquale, Alessandra Sacco, et al.
Pageof 4